NM_181426.2:c.1612C>G
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4BP6
The NM_181426.2(CCDC39):c.1612C>G(p.Leu538Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000258 in 1,543,608 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. L538R) has been classified as Uncertain significance.
Frequency
Consequence
NM_181426.2 missense
Scores
Clinical Significance
Conservation
Publications
- primary ciliary dyskinesia 14Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae)
- primary ciliary dyskinesiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_181426.2. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CCDC39 | NM_181426.2 | MANE Select | c.1612C>G | p.Leu538Val | missense | Exon 12 of 20 | NP_852091.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CCDC39 | ENST00000476379.6 | TSL:2 MANE Select | c.1612C>G | p.Leu538Val | missense | Exon 12 of 20 | ENSP00000417960.2 | ||
| CCDC39 | ENST00000651046.1 | c.1420C>G | p.Leu474Val | missense | Exon 11 of 19 | ENSP00000499175.1 | |||
| CCDC39 | ENST00000650641.1 | n.1499C>G | non_coding_transcript_exon | Exon 11 of 16 |
Frequencies
GnomAD3 genomes AF: 0.000171 AC: 26AN: 151918Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000124 AC: 19AN: 152808 AF XY: 0.000136 show subpopulations
GnomAD4 exome AF: 0.000267 AC: 372AN: 1391690Hom.: 0 Cov.: 28 AF XY: 0.000248 AC XY: 170AN XY: 686284 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000171 AC: 26AN: 151918Hom.: 0 Cov.: 32 AF XY: 0.0000944 AC XY: 7AN XY: 74190 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Primary ciliary dyskinesia Uncertain:2Benign:1
This sequence change replaces leucine with valine at codon 538 of the CCDC39 protein (p.Leu538Val). The leucine residue is moderately conserved and there is a small physicochemical difference between leucine and valine. This variant is present in population databases (rs377319302, ExAC 0.01%). This variant has not been reported in the literature in individuals affected with CCDC39-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at